EU project seeks algae omega-3s


- Last updated on GMT

EU project pursuing "high value products for nutrition and pharmaceutical applications"
EU project pursuing "high value products for nutrition and pharmaceutical applications"

Related tags: Eicosapentaenoic acid, Docosahexaenoic acid, Omega-3 fatty acid

Extracting omega-3 from novel algae sources is the mission of a European Union-funded project with multiple partners including the famed nutrition research arm at Wageningen University in the Netherlands.

The PUFAchain​ project focuses on the value chain of microalgae”​  - an area of the foodchain that has been attracting more and more interest in recent years due to nutrient stores and sustainability wins.

“The main targeted application is the use of high purified omega-3 fatty acids (DHA [docosahexaenoic acid] and EPA [eicosapentaenoic acid] as building blocks in modern oleo chemistry to gain high value products for nutrition and pharmaceutical applications,”​ the project outline states.

It adds: “These stages include biology, cultivation technology and downstream technology”  ​to establish a “concrete exemplary value chain”.

150 strains have been preselected and “5-10 strains will be selected analysed in detail and prepared for upscaling.

“…best available expertise in the sector in Europe.”

Six firms and two research institutions are involved aside from Wageningen that will engage at various points along the whole supply chain.

This would encompass feedstock production and harvesting to oil extraction and purification.”

“Innovative technologies will be combined taking advantage of a complimentary partnership with the best available expertise in the sector in Europe. These processes will be evaluated for their sustainability and scaled-up from lab to demonstrative prototype level.”
The other partners are:

  • Georg-August-University Goettingen (Netherlands)
  • A4F: Algae For Future Algafuel (Portugal)
  • Mahle (Germany)
  • Natex Prozesstechnologie (Austria)
  • Cremer Oleo Division (Germany)
  • Fraunhofer IZI (Germany)
  • Institute for Energy and Environmental Research Heidelberg (Germany)
  • EurA Consult (Germany)
algae protein marine

EPA and DHA are backed for brain, eye, foetus and cardiovascular benefits under the EU's tough nutrition and health claims regulation (NHCR).

The biggest algae-sourced omega-3 supplier is DSM which gained supremacy in the space when it paid about €800m for Maryland, US-based specialist Martek Biosciences in 2011.

Others in the algae extraction space include French supplier Roquette, Allma in Portugal and Aurora Algae in California for the likes of spirulina and chlorella.

Related news

Show more

Related products

show more

Pycnogenol® Provides Benefits for Men Managing ED

Pycnogenol® Provides Benefits for Men Managing ED

Horphag Research | 17-Feb-2020 | Clinical Study

Newly published research shows daily supplementation with Pycnogenol® can strengthen erectile function and address common conditions related to type 2...



SABINSA | 27-Jan-2020 | Data Sheet

Sabinsa’s patented, colorless, Curcumin C3 Reduct® is 250 times more effective than curcumin in activating AMP Kinase (Intracellular Fuel Gauge). This...

HRB are ideal probiotics for human health

HRB are ideal probiotics for human health

Morinaga Milk Industry Co., Ltd. | 13-Jan-2020 | Technical / White Paper

Evidence is accumulated that the physiological benefits of probiotics bifidobacteria are not only strain-specific but also dependent on their residential...

Related suppliers

Follow us

Featured Events

View more


View more